Last edition
News about "Glenmark"
Indian Pharmaceutical Alliance Welcomes New Leadership
Dr. Sharvil Patel, Managing Director, Zydus Lifesciences, and Vice President, Indian Pharmaceutical Alliance (IPA), has been appointed President of the alliance, while Glenn Saldanha, Chairman and Managing Director, Glenmark, will serve as the new Vice President.
Glenmark | 04/10/2025 | By Dineshwori | 107
Glenmark Secures USD 1.0 Billion Licensing Deal for Next-Gen Cancer Drug with Chinese Partner
Under the terms of the deal, Glenmark will make an upfront payment of USD 18 million and may pay up to USD 1.093 billion in regulatory and commercial milestone payments, in addition to royalties tied to future sales.
Glenmark | 25/09/2025 | By Darshana
Cosmo and Glenmark Receive UK MHRA Approval of Winlevi for Treatment of Acne
Winlevi® is a topical treatment for acne vulgaris in patients aged 12 years and older, marking a significant milestone in the commitment of both companies to providing innovative, patient-focused dermatology solutions.
Glenmark | 10/02/2025 | By Aishwarya | 314
Glenmark Rolls Out Travoprost Ophthalmic Solution
Glenmark’s Travoprost Ophthalmic Solution USP, 0.004 percent is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004 percent of Sandoz, Inc.
Glenmark | 27/11/2024 | By Aishwarya | 194
Glenmark Gets ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules
Glenmark has secured final approval by the United States Food & Drug Administration (US FDA) for Esomeprazole Magnesium Delayed-Release Capsules.
Glenmark | 15/06/2024 | By Aishwarya | 254
Glenmark Signs Exclusive Marketing and Distribution Deal with BeiGene
Glenmark has signed an exclusive marketing and distribution agreement with BeiGene, a global oncology company.
Glenmark | 21/05/2024 | By Aishwarya | 729
Glenmark, Strides Pharma, Cipla recalls products in US
The products were recalled due to manufacturing issues
Glenmark | 22/08/2022 | By Sudeep Soparkar | 1074
Pharma cos recall products in US due to manufacturing issues
Sun Pharma is recalling the affected lot due to "water leakage" leading to deviation from current good manufacturing practices (cGMP)
Glenmark | 25/07/2022 | By Sudeep Soparkar | 602
Glenmark | 28/06/2022 | By Sudeep Soparkar | 558
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy